Page 25 - WNS 2024 -e-Program Edition_Neat
P. 25

Same-Day Discharge Pathway in DBS Electrode Placement
          Surgery
          Farrokh Farrokhi, MD Virginia Mason Franciscan Health
          Aaradhya Pant, BS, Stanford School of Medicine; Christine Palermo, MD,
          Virginia Mason Franciscan Health; Samira Pardakhtim, ARNP, Univ. of
          Washington School of Medicine; John Roberts, MD, Virginia Mason
          Franciscan Health; Sindhu Srivatsal, MD, Virginia Mason Franciscan Health
          Maria Marsans, PAC, Virginia Mason Franciscan Health
          Introduction: Deep Brain Stimulation (DBS) surgery has evolved
          into a highly effective procedure for treating an expanding number of
          neurological conditions. While DBS surgery has demonstrated low
          rates of serious complications, it is typically followed by an inpatient
          hospital stay.  A primary barrier to discharging patients same-day is
          uncontrolled postoperative hypertension, which may lead to serious
          complications such as intracranial hemorrhage.
          In recent years, a combination of limited hospital resources, the growing
          demand for DBS, and other restrictions on elective, hospital-based
          procedures have contributed to a shift in the care model.  Access to elective
          surgeries are further limited due to the ongoing nursing shortage and
          preferences of nurses for working in outpatient settings.  To preserve
          inpatient resources and increase patient accessibility, a transition to
          outpatient DBS surgery or same-day discharge following DBS surgery is
          emerging. This discharge model has been previously reported as safe.
          However, to our best knowledge, no study has evaluated which patient
          factors can be leveraged to guide the selection of patients suitable for same-
          day discharge.
          Methods: Commencing in January 2022, our institution began a rapid
          discharge pathway for DBS patients on the same day following surgery. This
          change in practice provided two cohorts: patients in the same-day pathway
          and inpatient overnight pathway. Here, we first retrospectively analyzed
          these two cohorts from January 2022 to July 2023 to determine (1) which, if
          any, pre-operative factors can predict whether a patient will be discharged
          same-day and (2) how these pre-operative factors could influence patient
          selection for same-day discharge.
          Results: We found no discernible pre-operative factors to predict the
          likelihood of same-day discharge after DBS surgery. Recognizing the
          limitations of pre-operative factors, combined with uncontrolled
          hypertension being a known barrier to early discharge, we subsequently
          focused on postoperative antihypertensive medication administration in all
          patients prior to January 2022. Our analysis underscores the potential for a
          significant proportion of patients to be considered for same-day discharge
          based on better preoperative hypertension management, potentially leading
          to significant healthcare cost savings.
   20   21   22   23   24   25   26   27   28   29   30